Megan Lerner to Spectrometry, Mass, Electrospray Ionization
This is a "connection" page, showing publications Megan Lerner has written about Spectrometry, Mass, Electrospray Ionization.
Connection Strength
0.237
-
Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer. 2011 Nov; 74(2):206-11.
Score: 0.093
-
Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery. PLoS One. 2020; 15(8):e0234539.
Score: 0.044
-
Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett. 2015 Apr 10; 359(2):314-24.
Score: 0.030
-
Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
Score: 0.028
-
Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling. Cancer Invest. 2011 Feb; 29(2):173-9.
Score: 0.023
-
Biomarker identification in human pancreatic cancer sera. Pancreas. 2008 Jan; 36(1):61-9.
Score: 0.018